Abstract:Objective To risk assessment model of vulvar intraepithelial neoplasia established by clinical and epidemiological data. Methods The clinical and epidemiological data of 101 cases with intraepithelial neoplasia, 134 cases with benign lesions, and 150 cases with completely normal vulva were collected. The clinical data were analyzed by single factor analysis, the cut-off values of influencing factors were obtained by ROC curve, the logistic regression model was constructed, and the accuracy of the model was verified by using confusion matrix back analysis. Results Logistic regression analysis: Age, smoking, human papillomavirus (HPV) infection, pruritus of vulva, blood contact of vulva, tumor of vulva, pain of vulva, menopause or not, absolute value of neutrophils (GRA), ratio of neutrophils to lymphocytes (NLR), serum carbohydrate antigen 125 (CA125) index were concluded in the regression equation. The maximum likelihood ratio (LR) test of regression model showed significant difference (P < 0.05). The results of obfuscation matrix analysis showed that the overall prediction accuracy of the model is 78.44% (302/385). Conclusions The risk assessment model of vulvar intraepithelial neoplasia was established by using epidemiological and clinical data, and can effectively improve the correct screening rate of vulvar intraepithelial neoplasia.